Skip to search formSkip to main contentSkip to account menu

Levothyrox

Known as: Lévothyrox 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
In France, more than 2.5 million patients are currently treated with levothyroxine, mainly as the marketed product Levothyrox… 
2019
2019
  • P. Nicolas
  • Clinical Pharmacokinetics
  • 2019
  • Corpus ID: 174806453
I read with interest the article published in Clinical Pharmacokinetics by Didier Concordet and colleagues [1], who reported an… 
Review
2019
Review
2019
In a recent ‘Current Opinion’ paper in Clinical Pharmacokinetics, Concordet et al. [1] postulated that the withinsubject variance… 
2019
2019
  • P. Tréchot
  • Clinical Pharmacokinetics
  • 2019
  • Corpus ID: 186204326
I read with particular interest the article by Concordet et al. [1] entitled “Levothyrox® new and old formulations: are they… 
Review
2019
Review
2019
We are pleased to respond to the letter of Coste at al. [1] as follows. Nowhere in our article is any claim made to analyse the… 
2019
2019
At the request of French Regulatory Authorities, a new formulation of Levothyrox ® was licensed in France in 2017, with the… 
2019
2019
Retrospective analyses of data generated in clinical trials can provide valuable contributions to drug development and stimulate… 
Review
2018
Review
2018
Since patients may report spontaneously adverse events associated with their medications, such notifications are constantly on… 
2017
2017
Abstract Objective: Small levothyroxine (L-T4) dose changes can lead to significant clinical effects. To ensure thyroid hormone… 
2008
2008
A 24-year-old adult with a Down syndrome was admitted in December 2006 at the Moutiers hospital in the French Alps for an acute…